Beware overestimation of thrombosis in ICU: Mortality is not the only competing risk!

Jaime F Borjas-Howard¹, Soerajja Bhoelan², Jasper van Miert², Ruben Eck³, Hilde A M Kooistra², Karina Meijer², Vladimir Y I G Tichelaar²

Affiliations

¹ Department of Hematology, Division of Thrombosis and Hemostasis, University Medical Centre Groningen, University of Groningen, the Netherlands. Electronic address: j.f.borjas.howard@umcg.nl.
² Department of Hematology, Division of Thrombosis and Hemostasis, University Medical Centre Groningen, University of Groningen, the Netherlands.
³ Department of Internal Medicine, University Medical Centre Groningen, University of Groningen, the Netherlands.

PMID: 32526544
DOI: 10.1016/j.thromres.2020.05.019

Comment

Beware overestimation of thrombosis in ICU: Mortality is not the only competing risk!

Jaime F Borjas-Howard et al. Thromb Res. 2020 Sep.

. 2020 Sep:193:78.

doi: 10.1016/j.thromres.2020.05.019. Epub 2020 May 30.

Authors

Jaime F Borjas-Howard¹, Soerajja Bhoelan², Jasper van Miert², Ruben Eck³, Hilde A M Kooistra², Karina Meijer², Vladimir Y I G Tichelaar²

Affiliations

¹ Department of Hematology, Division of Thrombosis and Hemostasis, University Medical Centre Groningen, University of Groningen, the Netherlands. Electronic address: j.f.borjas.howard@umcg.nl.
² Department of Hematology, Division of Thrombosis and Hemostasis, University Medical Centre Groningen, University of Groningen, the Netherlands.
³ Department of Internal Medicine, University Medical Centre Groningen, University of Groningen, the Netherlands.

PMID: 32526544
DOI: 10.1016/j.thromres.2020.05.019

No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest Dr. Meijer reports grants and other from Bayer, grants and other from Sanquin, grants from Pfizer, other from Boehringer Ingelheim, other from BMS, other from Aspen, other from Uniqure, outside the submitted work; No other conflicts of interest.

Comment on

Incidence of thrombotic complications in critically ill ICU patients with COVID-19.
Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers DAMPJ, Kant KM, Kaptein FHJ, van Paassen J, Stals MAM, Huisman MV, Endeman H. Klok FA, et al. Thromb Res. 2020 Jul;191:145-147. doi: 10.1016/j.thromres.2020.04.013. Epub 2020 Apr 10. Thromb Res. 2020. PMID: 32291094 Free PMC article.
Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis.
Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers D, Kant KM, Kaptein FHJ, van Paassen J, Stals MAM, Huisman MV, Endeman H. Klok FA, et al. Thromb Res. 2020 Jul;191:148-150. doi: 10.1016/j.thromres.2020.04.041. Epub 2020 Apr 30. Thromb Res. 2020. PMID: 32381264 Free PMC article.
Thrombotic complications of patients admitted to intensive care with COVID-19 at a teaching hospital in the United Kingdom.
Thomas W, Varley J, Johnston A, Symington E, Robinson M, Sheares K, Lavinio A, Besser M. Thomas W, et al. Thromb Res. 2020 Jul;191:76-77. doi: 10.1016/j.thromres.2020.04.028. Epub 2020 Apr 25. Thromb Res. 2020. PMID: 32402996 Free PMC article. No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Beware overestimation of thrombosis in ICU: Mortality is not the only competing risk!

Affiliations

Beware overestimation of thrombosis in ICU: Mortality is not the only competing risk!

Authors

Affiliations

Conflict of interest statement

Comment on

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical